Monday, May 11, 2009

Down with the gown

A hospital gown's design seems frivolous -- until you are doubled over with fever and exhaustion and chemo trying to tie the damn thing up with trembling fingers.

Today's Wall Street Journal has a nice piece about fledgling efforts to reform the johnny. How about making it easy to fasten? A pocket, perhaps? Make the fit a little more flexible and less prone to indecent exposure? And, of course, any new design also has to be ridiculously durable and affordable if it is to have any chance of replacing the old:

The traditional American hospital gown -- flimsy in front, open to the breeze in the back -- has been around about as long as the Band-Aid. If anything, it has changed less.

The one-size-fits-none garment remains one of the least loved aspects of American medicine.

I have a little more about the healing power of hospital aesthetics in this old post.
A faded poster of golden retriever puppies peeking out of pastel flower pots was taped to the ceiling directly above the bench where patients lie [during radiation]. I guess the idea was that people could distract themselves with fluffy puppies while their flesh burned.

Friday, May 8, 2009

... and something genuinely encouraging

It was posted in 2006, but I enjoyed reading Jeanne Sather's piece Don't Write Me Off in the midst of my grays. Four-and-a-half years ago, an M.D. Anderson doctor told her further treatment for metastatic breast cancer was "... reaching the limits of futility."

Futility. It's 2009, she has other doctors, and she's vehemently still here.

The piece also reports on yet another M.D. Anderson dirty secret: They don't routinely give second opinions (at least not to breast cancer and sarcoma patients). Why not? They aren't profitable.

Fear not, y'all!

Senator Arlen Specter is on the case.

The man with no friends -- Republicans, understandably, despise him and Democrats, understandably, mistrust him -- is going to beat cancer. In fact, he is going to build a bridge over the valley of death.

Feel better?


For years and years, billions of your tax dollars have paid for medical research. There have been great discoveries – actually, we learn more every day – but where are the cures?

Between scientific discoveries and treatments which help ailing Americans is what many researchers call a “valley of death”. People are suffering, even losing their lives, who need not.

Today, that starts to change. Senator Arlen Specter intends to build a bridge over the valley of death.

Thursday, May 7, 2009

Gray

I'm trying to write and nothing comes. I've always found the bad times the hardest to capture: It's easy to get motivated to tell stories or to show what the kids were like in the hotel pool, gleaming and streaming like pale seals, hair slicked back so their bright eyes and huge grins seem bigger than life and suddenly grant fresh understanding of the word "radiant." But the blah stuff, the grinding pain, melancholy, worry, sleeplessness -- who cares about that? Or, rather, who cares to write about it?

I want to be honest, but I also have an intense desire to be liked. We are conditioned to be cheerful and optimistic, after all. Or at least to overvalue those traits. I imagine my pain making me unlikeable -- after all, I don't like it. I'm not going to break through that barrier today, and I probably lack the skills to illustrate what the last few days have been like even if I cared to. My writing palette lacks the number of shades of gray I would need to delineate the mental and physical ache of a stubborn disease.

I'm in a gray place: Thick, clammy fog or the smear of a dirty pencil eraser. I am curled up there hurting and waiting for the love of my family to bring me once again into the light.

Wednesday, May 6, 2009

H-E-double hockey sticks

I was perusing the Sarcoma Alliance blog and stopped to chuckle at a T-shirt someone was wearing at a benefit run: "What the hell is a sarcoma?" (I have answers to that, yes I do.) I kept reading and found that the shirt had provoked a minor controversy, spawning a redesigned version sans the blunt reference to a place of eternal torment. Both are available here.

By the way, I'd encourage sarcoma patients to repopulate the once-useful resource of the Sarcoma Alliance's bulletin board. A switch to new software and a different registration process seems to have reduced traffic there, which is a shame.

Tuesday, May 5, 2009

Sarcoma on Twitter

I didn't see the point of Twitter from reading about it, so I signed up for an account a few days ago in order to get a sense of what it was all about. I didn't want to use my real name -- and I thought "Sick Guy" might sound weird without any context -- so I made a millisecond decision to log on as sarcomaguy. (I guess that choice tells us, again, what's usually on my mind.)

After a few days of goofing around reading what some smart writers and bloggers muse about when they are procrastinating, a strange thing happened: Some strangers decided to become my "followers." Since one can hardly disappoint a "follower," I wrote a couple of posts, er, "tweets." I've now impulsively decided that I am going to try to keep sarcomaguy updated with little observations, tips, links and thoughts from the world of sarcoma. I don't envision that many people will be checking it in real time on their cell phones, but I will also occasionally post personal breaking news -- scan results and the like. That said, the focus will be broader (and shallower) than here -- I'll probably link to some of the great stuff that, say, the Liddy Shriver Sarcoma Initiative puts out that doesn't directly apply to epithelioid sarcoma. If the feed can attract a little interest, I'll do my best to find good stuff to share on it.

Anyway, feel free to join my tiny band of followers and say hello if Twitter interests you.

Must I live with you, Pain?

Bill Stuntz is a professor of law at Harvard facing metastatic colon cancer. He is also a conservative and evangelical Christian. His blog is wonderful, but I rarely read it -- a shame, since every time I do, I find something that influences or echoes my thoughts. Today I found at least three things I wanted to link to or comment on (including an interesting idea for Souter's replacement), but I'll stick to this poem about pain by Edna St. Vincent Millay.

And must I then, indeed, Pain, live with you
All through my life? Sharing my fire, my bed,
Sharing — oh, worst of all things! — the same head? —
And, when I feed myself, feeding you, too?
So be it, then, if what seems true, is true:
Let us to dinner, comrade, and be fed:
I cannot die till you yourself are dead,
And, with you living, I can live life through.
Yet have you done me harm, ungracious guest,
Spying upon my ardent offices
With frosty look; robbing my nights of rest;
And making harder things I did with ease.
You will die with me: but I shall, at best,
Forgive you with restraint, for deeds like these.

Sunday, May 3, 2009

Snacks (or attacks?)

Proving that there's a home for anything on the web, a blog is devoting itself to showing pictures of hospital food from around the world. Some of the foreign stuff actually looks OK, and the Japanese, of course, win for presentation.

Friday, May 1, 2009

Briva-not

Yesterday, my blood pressure came in at 90 over 64 -- nowhere near convincing me that I'm mistaken about having been randomized into the placebo group.

That leaves me with the absurdity of sitting down on my bed each evening before sleep, getting out a formidable white bottle marked brivanib OR placebo, and swallowing four big pills. (Kathy also believes/knows she's in the placebo group; her take on swallowing the probably inert pills was something like "these taste like smarties." I laughed; it beats driving a fist through the wall.)

I've looked at the bottles closely; no clues, no A or B or 0 or 1 at the end of a reference number that might indicate the contents. The pills themselves look and feel the same. I notice -- or think I have -- that the presumed-placebo brivanib pills soften in my mouth quicker than the real deal did; if I don't wash them down quickly, which isn't the easiest thing since they are the size and shape of torpedos, the pills develop a gluey quality. The first time this happened, I thought, "Paste eater!" to myself. (I think that might have been a bizarre insult hurled by a nasty schoolgirl in one of the Lemony Snicket series of unfortunate events books.)

I wonder, but I could just cheat the study. I received a full bottle of real brivanib just as my lung problems started to ramp up. No one confiscated them during or after my hospitalization. I could swap out a pill -- since I imagine the brivanib in my possession will be destroyed when I return it -- and fool around with it and definitively see if there are any differences with what I'm taking now. I could have even, I suppose, taken the real pills instead of the placebo this go 'round, though I wouldn't want any tumor-smashing success mistakenly attributed to the paste pills. I'm also way too much of a goody-goody to break any rules, so the point is moot even though I look at my bagged bottle of the real stuff longingly.

I know this is an inert post (albeit with accidental bonus bad jokes), but it's hard not to get obsessed with this kind of stuff if you are in a placebo-controlled trial. It's hard, even, to leave it behind when you know you are no longer on drug. So chalk this one up for the other folks in the brivanib study who are dealing with this now or may have to deal with it in the future.

Fame!

Seattle Times columnist Nicole Brodeur has a nice write-up on Josh and an upcoming screening of his epithelioid sarcoma documentary My Left Hand.

The camera sits in on Isaac's appointments at the University of Washington Medical Center, his pensive strolls through Gas Works Park. The roughhousing with his two young sons.

There is a strange sort of fun in a scene in which Isaac allows his son to pull out clumps of his hair after chemotherapy; and another in which his friends supportively shave their heads at Rudy's Barbershop.

But there is great sadness watching Isaac remove his wedding ring, since he won't have the hand to wear it.